ListarFHEFD - Contribuciones a congresos científicos por tema "Medicamentos - Efectividad - Congresos"
Mostrando ítems 1-1 de 1
New augmentation strategy in depression: Galanin (1-15) enhances the behavioral effects of Fluoxetine in the olfactory bulbectomy rat. (2022-07-12)Major depression is the largest contributor to global disability by years lived with disability. Selective serotonergic reuptake inhibitors, including fluoxetine (FLX), are the most commonly used antidepressant for the ...